Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Antiviral Effect in Hepatitis C
NCT00403533Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin in hepatitis C (HCV), sponsored by Massachusetts General Hospital. Primary endpoint: HCV Viral Load at 12 weeks. Started Feb 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00403533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403533.